ANTIOP, INC.

Basic Information

3732 Wembley Lane
LEXINGTON, KY, 40515-

Company Profile

n/a

Additional Details

Field Value
DUNS: 831025338
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Naloxone Nasal Spray Development

    Amount: $2,986,389.00

    DESCRIPTION: The following proposal is a follow-on Phase 2 b application from our initial proposal (1-R42 DA 030001). U.S. drug overdose deaths, mostly commonly from opioids, now exceed deaths from a ...

    STTR Phase II 2013 Department of Health and Human Services
  2. Intranasal Naloxone: An Opioid Overdose Antidote

    Amount: $1,219,884.00

    DESCRIPTION (provided by applicant): There is a significant unmet medical need to provide additional pharmacologic treatments for treatment and prevention of opioid overdose. This Fast Track STTR proj ...

    STTR Phase II 2011 Department of Health and Human Services
  3. Intranasal Naloxone: An Opioid Overdose Antidote

    Amount: $239,908.00

    DESCRIPTION (provided by applicant): There is a significant unmet medical need to provide additional pharmacologic treatments for treatment and prevention of opioid overdose. This Fast Track STTR proj ...

    STTR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government